PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50324F63003 — OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE)

OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE) is a federal award for Department of Health and Human Services (HHS) held by ALVOGEN INC.. Estimated value $74.5M ($74.5M obligated). Current period of performance ends Sep 28, 2027. Last award drew 8 bidders. Place of performance: MORRISTOWN, NJ. Related solicitation 75A3234Q00019.

$74.5M
Estimated Value
Sep 28, 2027
PoP End / Expires
8
Bidders (last award)
ALVOGEN INC.
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

ALVOGEN INC. holds $284.8M across 11 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 8 offers. Recompete timing centers on the Sep 28, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number75A50324F63003
AgencyDepartment of Health and Human Services (HHS)
IncumbentALVOGEN INC.
UEILJNNGDV77Y98
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV75A50119D00035
Place of performanceMORRISTOWN, NJ
Related solicitation75A3234Q00019
PoP end (current)Sep 28, 2027
Obligated$74.5M

OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE)

Recompete timing

Public
Expiring in 407 days

Current PoP ends Sep 28, 2027 (407 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Watch this contract — one email →

Incumbent footprint

Public record

ALVOGEN INC.$284.8M obligated across 11 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$284.8M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50324F63003
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open ALVOGEN INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50324F63003?

75A50324F63003 (OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE)) is a Department of Health and Human Services (HHS) award with an estimated value of $74.5M, currently held by ALVOGEN INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50324F63003?

ALVOGEN INC. is the incumbent with $284.8M across 11 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2027.

When does 75A50324F63003 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50119D00035-75A50324F63003